Τόμος 32 (2014) – Τεύχος 2 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 32 (2014) – Issue 2 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Ουρανία Βαρσαμά και Αθανασία Βαρβαρέσου
Εργαστήριο Κοσμητολογίας, Τμήμα Αισθητικής και Κοσμητολογίας, Τεχνολογικό Εκ-παιδευτικό Ίδρυμα Αθήνας, Αγ.Σπυρίδωνα, 12210 Αιγάλεω, Αθήνα, Ελλάς  –
Ourania Varsama and Athanasia Varvaresou
Laboratory of Cosmetology, Department of Aesthetics and Cosmetology, Technological Educational Institution, Ag. Spyridonos Str., GR-12210 Egaleo, Athens, Hellas

4.http://www.fda.gov/Cosmetics/ProductandIngredientSafety/SelectedCosmeticIngredients/ucm128042.htm. US Food and Drug Administration – Parabens.

5. Soni M.G., Garabin I.G., Burdock G.A.: Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem. Toxicol. 43: 985-1015 (2005)

6. Tavares R.S., Martins F.C., Oliveira P.J., Ramalho-Santos J., Peixoto F.P.: Parabens in male infertility. Is there a mitochondrial connection? Reprod. Toxicol. 27: 1-7 (2009)

7. Soni M.G., Taylor S.L., Greenberg N.A., Burdock G.A.: Evaluation of the health aspects of methyl paraben: A review of the published literature. Food Chem. Toxicol. 40: 1335-1373 (2002)

8. Pedersen S., Marra F., Nicoli S., Santi P.: In vitro skin permeation and retention of parabens from cosmetic formulations. Int. J. Cosmet. Sci. 29: 361-367 (2007)

9. Aubert N., Ameller T., Legrand J.J.: Systemic exposure to parabens: Pharmacokinetics, tissue distribution, ex-cretion balance and plasma metabolites of [¹⁴C]-methyl-, propyl- and butylparaben in rats after oral, topical or subcutaneous administration. Food Chem. Toxicol. 50: 445-454 (2012)

10. Darbre P.D. Aljarrah A., Miller W.R., Coldham N.G., Sauer M.J., Pope G.S.: Concentrations of parabens in human breast tumours. J. Appl. Toxicol. 24: 5-13 (2004)

11. Soni M.G., Burdock G.A., Taylor S.L., Greenberg N.A.: Safety assessment of propyl paraben: a review of the published literature. Food Chem. Toxicol. 39: 513-532 (2001)

12. SCCP/0874/05 – Opinion of the Scientific Committee on Consumer Products on the safety evaluation of parabens, underarm cosmetics and breast cancer, adopted by written procedure on 28 January 2005.

13. The European Commission Directorate General Health and Consumers. Public consultation on parabens. In the framework of Regulation (EC) No 1223/2009 of the European Parliament and the Council on Cosmetic Products.

14. SCCS/1446/11: Clarification on opinion SCCS/1348/10 in the light of the Danish clause of safeguard banning the use of parabens in cosmetic products intended for children under three years of age, adopted by written procedure on 10 October 2011.

15. EFSA. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a Request from the Commission related to parahydroxybenzoates (E 214-219), Question number EFSA-Q-2004-063, adopted on 13 July 2004. The EFSA Journal 83: 2004, 1-26 (2004)

16. Ιωάννου-Κακούρη Ε. et al. Υπουργείο Υγείας – Γενικό Χημείο του Κράτους. Οδηγός για πρόσθετα τροφίμων (Αριθμοί Ε), 2008, 42-44.

17. http://www.food-info.net/gr/e/e200-300.htm. FoodInfo-Since 1999. E200-E300 Συντηρητικά.

18. Vo T.T., Yoo Y.M, Choi K.C., Jeung E.B.: Potential estrogenic effect(s) of parabens at the prepubertal stage of a postnatal female rat model. Reprod. Toxicol. 29: 306-316 (2010)

19. Darwish R.M., Bloomfield S.F.: The effect of co-solvents on the antibacterial activity of paraben preservatives. Int. J. Pharm. 119: 183-192. (1995)

20. FDA. Part II, Department of Health, Education and Welfare. Food and Drug Administration. Ophthalmic Drug Products for Over-the-Counter Human Use; Establishment of a Monograph, Proposed Rulemaking. Federal Register, 45 (89), May 1980, Proposed Rules, 30020.

21. Boberg J., Taxvig C., Christiansen S., Hass U.: Possible endocrine disrupting effects of parabens and their metabolites. Reprod. Toxicol. 30: 301-312 (2010)

22. Nakagawa Y., Moldeus P.: Mechanism of p-hydroxybenzoate ester-induced mitochondrial dysfunction and cytotoxicity in isolated rat hepatocytes. Biochem. Pharmacol. 55: 1907-1914 (1998)

23. Schlumpf M., Kypke K,, Wittassek M,, Angerer J,, Mascher H,, Mascher D,, Vökt C,, Birchler M,, Lichten-steiger W.: Exposure patterns of UV filters, fragrances, parabens, phthalates, organochlor, pesticides, PBDEs, and PCBs in human milk: Correlation of UV filters with use of cosmetics. Chemosphere 81: 1171-1183 (2010)

24. Prusakiewicz J.J., Ackermann C., Voorman R.: Com-parison of skin esterase activities from different species. Pharm. Res. 23: 1517-1524 (2006)

25. Harville H.M., Voorman R., Prusakiewicz J.J. Com-parison of paraben stability in human and rat skin. Drug Metabol. Lett. 1(1): 17-21 (2007)

26. El Hussein S., Muret P., Berard M., Makki S., Humbert P.: Assessement of principal parabens used in cosmetics after their passage through human epidermis-dermis layers (ex-vivo study). Exp. Dermatol. 16: 830-836 (2007)

27. Ishiwatari S., Suzuki T., Hitomi T., Yoshino T., Matsu-kuma S., Tsuji T.: Effects of methyl paraben on skin keratinocytes. J. Appl. Toxicol. 27: 1-9 (2007)

28. Shirai S., Suzuki Y., Yoshinaga J., Shiraishi H., Mizumoto Y.: Urinary excretion of parabens in pregnant Japanese women. Reprod. Toxicol. 35: 96-101 (2013)

29. Ye X., Bishop A.M., Reidy J.A., Needham L.L., Calafat A.M.: Parabens as urinary biomarkers of exposure in humans. Environ. Health Perspect. 114: 1843-1846 (2006)

30. Ye X., Kuklenyik Z., Bishop A.M., Needham L.L., Calafat A.M.: Qualification of the urinary concentrations of parabens in humans by on-line solid phase extraction-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 844: 53-59 (2006)

31. Darbre P.D., Harvey P.W.: Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J. Appl. Toxicol. 28: 561-578 (2008)

32. Cowan-Ellsberry C., Robinson S.H.: Refining aggregate exposure: example using parabens. Regul. Toxicol.  Pharmacol. 55: 321-329 (2009)

33. Kopalli S.R., Noh S.J., Koppula S., Suh Y.H.: Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson’s disease. Neurotoxicology 34: 25-32 (2013)

34. Routledge E.J., Parker J., Odum J., Ashby J., Sumpter J.P.: Some alkyl hydroxy benzoate preservatives (Parabens) are estrogenic. Toxicol. Appl. Pharmacol. 153: 12-19 (1998)

35. Prusakiewicz J.J., Harville H.M., Zhang Y., Ackermann C., Voorman R.L.: Parabens inhibit human skin estrogen sulfotransferase activity: Possible link to paraben estrogenic effects. Toxicology 232: 248-256 (2007)

36. Shah M.G., Maibach H.I.: Estrogen and skin. An overview [abstract]. Am. J. Clin. Dermatol. 2: 143-50 (2001)

37. Okubo T., Yokoyama Y,, Kano K,, Kano I.: ER-de-pendent estrogenic activity of parabens assessed by pro-liferation of human breast cancer MCF-7 cells and expression of ERα and PR. Food Chem. Toxicol. 39: 1225-1232 (2001)

38. Hossaini A., Larsen J.J., Larsen J.C.; Lack of oestrogenic effects on food preservatives (parabens) in uterotrophic assays. Food Chem. Toxicol. 38: 319-323 (2000)

39. Pedersen K.L., Pedersen S.N., Christiansen L.B., Korsgaard B., Bjerregaard P.: Preservatives ethyl-, propyl- and butylparaben are oestrogenic in an in vivo fish assay. Pharmacol. Toxicol. 86: 110-113 (2000)

40. Oishi S.: Effects of propyl paraben on the male reproductive system. Food Chem. Toxicol. 40: 1807-1813 (2002)

41. Oishi S.: Effects of butylparaben on the male reproductive system. Toxicol. Ind Health 17: 31-39 (2001)

42. Oishi S.: Effects of butyl paraben on the male re-productive system in mice. Arch. Toxicol 76: 423-429 (2002)

43. Oishi S.: Lack of spermatotoxic effects of methyl and ethyl esters of p-hydroxybenzoic acid in rats. Food Chem. Toxicol. 42: 1845-1849 (2004)

44. Hoberman M., Schreur D.K., Leazer T., Daston G.P., Carthew P., Re T., Loretz L., Mann P.: Lack of effect of butylparaben and methylparaben on the reproductive system in male rats. Birth Defects Res. B Dev. Reprod. Toxicol. 83: 123-133 (2008)

45. Chen J., Ahn K.C., Gee N.A., Gee S.J., Hammock B.D., Lasley B.L.: Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products. Toxicol. Appl. Pharmacol. 221: 278-284 (2007)

46. Meeker J.D., Yang T., Ye X., Calafat A.M., Hauser R.: Urinary concentrations of parabens and serum hormone levels, semen quality parameters and sperm DNA damage. Environ. Health Perspect. 119: 252-257 (2011)

47. Shaw J., deCatanzaro D.: Estrogenicity of parabens revisited: Impact of parabens on early pregnancy and an uterotrophic assay in mice. Reprod. Toxicol. 28: 26-31 (2009)

48. Shanmugam, G., Ramaswamy B.R., Radhakrishnan V., Tao H.: GC-MS method for the determination of paraben preservatives in the human breast cancerous tissue. Microchem. J. 96: 391-396 (2010)

49. Darbre P.D.: Environmental oestrogens, cosmetics and breast cancer. Best Pract. Res. Clin. Endocrinol. Metab. 20: 121-143 (2006)

50. Hu Y., Zhang Z., Sun L., Zhu D., Liu Q., Jiao J., Li J., Qi M.: The estrogenic effects of benzylparaben at low doses based on uterotrophic assay in immature SD rats. Food Chem. Toxicol. 53: 69-74 (2013)

51. Byford J.R., Shaw L.E., Drew M.G., Pope G.S., Sauer M.J., Darbre P.D.: Oestrogenic activity of parabens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 80: 49-60 (2002)

52. Dagher Z., Borgie M., Magdalou J., Chahine R., Greige-Gerges H.: P-Hydroxybenzoate esters metabolism in MCF7 breast cancer cells. Food Chem. Toxicol. 50: 4109-4114 (2012)

53. Mirick K., Davis S., Thomas D.B.: Antiperspirant use and the risk of breast cancer. J. Natl. Cancer Inst.  94: 1578-1580 (2002)

54. McGrath K.G.: An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/de-odorants and underarm shaving. Eur. J. Cancer Prev. 12: 479-485 (2003)

55. Harvey P.W., Darbre P.: Endocrine disrupters and human health: Could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? A review of evidence and call for further research. J. Appl. Toxicol. 24: 167-176 (2004)

56. Harvey P.W., Everett D.J.: Regulation of endocrine-disrupting chemicals: Critical overview and deficiencies in toxicology and risk assessment for human health. Best Pract. Res. Clin. Endocrinol. Metab. 20: 145-165 (2006)

57. Lee A.H.: Why is carcinoma of the breast more frequent in the upper outer quadrant? A case series based on needle core biopsy diagnoses. Breast 14: 151-152 (2005)

58.http://www.efsa.europa.eu/en/efsajournal/pub/83.htm. European Food Safety Authority.

59. http://www.sciencedirect.com. Science Direct – The world’s leading full-text scientific database.

60. http://www.ncbi.nlm.nih.gov/. National Center for Biotechnology Information.